![Morgan Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morgan Conn
Nessuna posizione attualmente
Patrimonio netto: 163 278 $ in data 31/08/2026
Profilo
Morgan Conn formerly worked at PTC Therapeutics, Inc., as Vice President-Business Development from 2001 to 2017, Amherst College, as Assistant Professor, Century Therapeutics, Inc., as Chief Financial Officer from 2024 to 2025, and Pharvaris NV, as Chief Business Officer from 2017 to 2024.
Dr. Conn received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree from the University of Toronto.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/03/2025 | 79.648 ( 0,04% ) | 163 278 $ | 31/08/2026 |
Precedenti posizioni note di Morgan Conn
| Società | Posizione | Fine |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Direttore Finanziario/CFO | 11/07/2025 |
| PHARVARIS N.V. | Corporate Officer/Principal | 04/10/2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Morgan Conn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
